Massar Capital Management, LP

Position in AKBA — Akebia Therapeutics, Inc.

CIK 2037238 STAMFORD, CT

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,293

New position

Shares Held

17,801

first reported quarter

Ownership

0.006%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#115

of 169 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Massar Capital Management, LP holds $8,768,387 across 6 Drug Manufacturers - Specialty & Generic names. AKBA ranks #6 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	8,055	$4,364,440
2	LQDA	Liquidia Corp	27,797	$2,216,254
3	ALKS	Alkermes plc.	26,010	$1,362,924
4	ZTS	Zoetis Inc.	8,175	$587,455
5	HROW	Harrow, Inc.	5,110	$217,021
6	AKBA	Akebia Therapeutics, Inc. This page	17,801	$20,293

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,293	17,801	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.